Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

di Kukulska Aleksandra, Krajewska Jolanta, Gawkowska-Suwińska Marzena, Puch Zbigniew, Paliczka-Cieslik Ewa, Roskosz Jozef, Handkiewicz-Junak Daria, Jarzab Michał, Gubała Elzbieta, Jarzab Barbara
Pubblicazione 2010-11-01

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

di Kukulska, Aleksandra, Krajewska, Jolanta, Gawkowska-Suwińska, Marzena, Puch, Zbigniew, Paliczka-Cieslik, Ewa, Roskosz, Jozef, Handkiewicz-Junak, Daria, Jarzab, Michał, Gubała, Elzbieta, Jarzab, Barbara
Pubblicazione 2010

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patie...

di Handkiewicz-Junak, Daria, Roskosz, Jozef, Hasse-Lazar, Kornelia, Szpak-Ulczok, Sylwia, Puch, Zbigniew, Kukulska, Aleksandra, Olczyk, Tomasz, Piela, Andrzej, Paliczka-Cieslik, Ewa, Jarzab, Barbara
Pubblicazione 2009

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

di Krajewska, Jolanta, Jarzab, Michal, Kukulska, Aleksandra, Czarniecka, Agnieszka, Roskosz, Jozef, Puch, Zbigniew, Wygoda, Zbigniew, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Krol, Aleksandra, Handkiewicz-Junak, Daria, Jarzab, Barbara
Pubblicato in Nucl Med Mol Imaging (2019)

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma

di Kukulska, Aleksandra, Krajewska, Jolanta, Kolosza, Zofia, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Pawlaczek, Agnieszka, Puch, Zbigniew, Ficek, Kornelia, Lisik, Teresa, Sygula, Dorota, Wygoda, Zbigniew, Roskosz, Jozef, Wydmanski, Jerzy, Jarzab, Barbara
Pubblicato in Endocr Connect (2019)

SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility

di He, Huiling, Bronisz, Agnieszka, Liyanarachchi, Sandya, Nagy, Rebecca, Li, Wei, Huang, Yungui, Akagi, Keiko, Saji, Motoyasu, Kula, Dorota, Wojcicka, Anna, Sebastian, Nikhil, Wen, Bernard, Puch, Zbigniew, Kalemba, Michal, Stachlewska, Elzbieta, Czetwertynska, Malgorzata, Dlugosinska, Joanna, Dymecka, Kinga, Ploski, Rafal, Krawczyk, Marek, Morrison, Patrick J., Ringel, Matthew D., Kloos, Richard T., Jazdzewski, Krystian, Symer, David E., Vieland, Veronica J., Ostrowski, Michael, Jarząb, Barbara, de la Chapelle, Albert
Pubblicazione 2013